Association of Race, Substance Abuse, and Health Insurance Coverage With Use of Highly Active Antiretroviral Therapy Among HIV-Infected Women, 2005
Bibliographic Data
Objectives. We examined racial/ethnic disparities in highly active antiretroviral therapy (HAART) use and whether differences are moderated by substance use or insurance status, using data from the Women's Interagency HIV Study (WIHS). Methods. Logistic regression examined HAART use in a longitudinal cohort of women for whom HAART was clinically indicated in 2005 (N = 1354). Results. Approximately 3 of every 10 eligible women reported not taking HAART. African American and Hispanic women were less likely than were White women to use HAART. After we adjusted for potential confounders, the higher likelihood of not using HAART persisted for African American but not for Hispanic women. Uninsured and privately insured women, regardless of race/ethnicity, were less likely than were Medicaid enrollees to use HAART. Although alcohol use was related to HAART nonuse, illicit drug use was not. Conclusions. These findings suggest that expanding and improving insurance coverage should increase access to antiretroviral therapy across racial/ethnic groups, but it is not likely to eliminate the disparity in use of HAART between African American and White women with HIV/AIDS
Antiretroviral therapy · Cohort · Confounding · Ethnic group · Family medicine · Health care · Human immunodeficiency virus (HIV) · Logistic regression · Medicaid · Multicenter AIDS Cohort Study · Psychiatry · Substance abuse · Viral load · Demography · HIV, Drug Use, Sexual Risk · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Internal Medicine · Medicine · Gerontology
Enacted HIV-related stigma and breast-health beliefs and practices among African American women living with HIV
Stigma and racial/ethnic HIV disparities
Multi-Dimensional Risk Factor Patterns Associated with Non-Use of Highly Active Antiretroviral Therapy among Human Immunodeficiency Virus-Infected Women
An Epidemic in Evolution
HIV-Related Stigma and Viral Suppression Among African-American Women
Engagement in HIV Care Among HIV-Positive Men Who Have Sex with Men From 21 Cities in the United States
Pilot Randomized Controlled Trial of an Intervention to Improve Coping with Intersectional Stigma and Medication Adherence Among HIV-Positive Latinx Sexual Minority Men
Perceived Discrimination and Physical Health Among HIV-Positive Black and Latino Men Who Have Sex with Men
Envisioning Women-Centered HIV Care
Impacts of Medicaid Expansion on Health Insurance and Coverage Transitions among Women with or at Risk for HIV in the United States
Retention in care and antiretroviral therapy adherence among Medicaid beneficiaries with HIV, 2001–2015
Transitioning HIV-infected adolescents to adult care at 14 clinics across the United States
Linking HIV-positive adolescents to care in 15 different clinics across the United States
The State of Disparities in Opportunistic Infection Prophylaxis for Blacks With HIV/Aids
Disparities in Receipt of Antiretroviral Therapy Among HIV-infected Adults (2002–2008)
Trends in Racial/Ethnic Disparities Among Patients Living with HIV in Texas, 1996 to 2013
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
The Womenʼs Interagency HIV Study
Variations in the Care of HIV-Infected Adults in the United States
The CES-D Scale
Combination antiretroviral therapy
Association of Medical Insurance and Other Factors With Receipt of Antiretroviral Therapy
Medically Eligible Women Who Do Not Use Haart
Longitudinal Relationships Between Use of Highly Active Antiretroviral Therapy and Satisfaction With Care Among Women Living With HIV/Aids
Use of Highly Active Antiretroviral Therapy in a Cohort of HIV-Seropositive Women
Health and Federal Budgetary Effects of Increasing Access to Antiretroviral Medications for HIV by Expanding Medicaid
Black–White Mortality From HIV in the United States Before and After Introduction of Highly Active Antiretroviral Therapy in 1996
| Unique citing works | 16 |
|---|---|
| Citations per year | 1 |
| Citation span | 2010 - 2024 (15) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 13 |